| Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations in SDHB and SDHD CJ Ricketts, JR Forman, E Rattenberry, N Bradshaw, F Lalloo, L Izatt, ... Human mutation 31 (1), 41-51, 2010 | 416 | 2010 |
| Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families S Igreja, HS Chahal, P King, GB Bolger, U Srirangalingam, L Guasti, ... Human mutation 31 (8), 950-960, 2010 | 210 | 2010 |
| Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort J Dénes, F Swords, E Rattenberry, K Stals, M Owens, T Cranston, ... The Journal of Clinical Endocrinology & Metabolism 100 (3), E531-E541, 2015 | 183 | 2015 |
| Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH‐B) gene mutation carriers U Srirangalingam, L Walker, B Khoo, F MacDonald, D Gardner, TJ Wilkin, ... Clinical endocrinology 69 (4), 587-596, 2008 | 111 | 2008 |
| Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non‐syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma M Jafri, J Whitworth, E Rattenberry, L Vialard, G Kilby, AV Kumar, L Izatt, ... Clinical endocrinology 78 (6), 898-906, 2013 | 92 | 2013 |
| Modeling congenital adrenal hyperplasia and testing interventions for adrenal insufficiency using donor-specific reprogrammed cells G Ruiz-Babot, M Balyura, I Hadjidemetriou, SJ Ajodha, DR Taylor, ... Cell Reports 22 (5), 1236-1249, 2018 | 70 | 2018 |
| Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours U Srirangalingam, B Khoo, L Walker, F MacDonald, RH Skelly, E George, ... Endocrine-related cancer 16 (2), 515-525, 2009 | 53 | 2009 |
| Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers N Tufton, L Shapiro, U Srirangalingam, P Richards, A Sahdev, AV Kumar, ... Clinical Endocrinology 86 (2), 286-296, 2017 | 44 | 2017 |
| SDHA mutated paragangliomas may be at high risk of metastasis N Tufton, R Ghelani, U Srirangalingam, AV Kumar, WM Drake, ... Endocrine-related cancer 24 (7), L43-L49, 2017 | 30 | 2017 |
| Klinefelter syndrome: going beyond the diagnosis G Butler, U Srirangalingam, J Faithfull, P Sangster, S Senniappan, ... Archives of disease in childhood 108 (3), 166-171, 2023 | 26 | 2023 |
| Changing pattern of referral to a diabetes clinic following implementation of the new UK GP contract U Srirangalingam, SK Sahathevan, SS Lasker, TA Chowdhury British Journal of General Practice 56 (529), 624-626, 2006 | 19 | 2006 |
| Oncometabolite induced primary cilia loss in pheochromocytoma SM O’Toole, DS Watson, TV Novoselova, LEL Romano, PJ King, ... Endocrine-related cancer 26 (1), 165-180, 2019 | 12 | 2019 |
| Repair of aberrant splicing in growth hormone receptor by antisense oligonucleotides targeting the splice sites of a pseudoexon A David, U Srirangalingam, LA Metherell, B Khoo, AJL Clark The Journal of Clinical Endocrinology & Metabolism 95 (7), 3542-3546, 2010 | 11 | 2010 |
| International FIPA Consortium: Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families S Igreja, HS Chahal, P King, GB Bolger, U Srirangalingam, L Guasti, ... Hum Mutat 31, 950-960, 2010 | 10 | 2010 |
| Succinate dehydrogenase B (SDHB)-associated bladder paragangliomas U Srirangalingam, A Banerjee, P Patki, J Peters, E George, SL Chew, ... Clinical Genitourinary Cancer 15 (1), e131-e136, 2017 | 9 | 2017 |
| Adrenal haemorrhage and infarction in the setting of vaccine-induced immune thrombocytopenia and thrombosis after SARS-CoV-2 (Oxford–AstraZeneca) vaccination A Graf, E Armeni, L Dickinson, M Stubbs, B Craven, U Srirangalingam, ... Endocrinology, Diabetes & Metabolism Case Reports 2022 (1), 2022 | 8 | 2022 |
| Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia RJ Auchus, O Hamidi, R Pivonello, I Bancos, G Russo, SF Witchel, ... New England Journal of Medicine, 2024 | 7 | 2024 |
| Renal replacement therapy as a treatment for severe refractory hypercalcemia. JF Pittaway, U Srirangalingam, PL Hanson, P Jones, WM Drake Minerva Endocrinologica 39 (3), 231-233, 2014 | 7 | 2014 |
| Cushing's syndrome with low levels of serum cortisol: the role of inhaled steroids AC Matos, U Srirangalingam, T Barry, AB Grossman Clinical medicine 11 (4), 404-405, 2011 | 6 | 2011 |
| Thrombolysis beyond 3 hours for acute ischaemic stroke R Selvaratnam, U Srirangalingam, S Ahmad, P Goulden Emergency Medicine Journal 26 (10), 756-757, 2009 | 6 | 2009 |
